Royal London Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-23,978
Closed -$2.56M 652
2024
Q2
$2.56M Buy
23,978
+1,215
+5% +$130K 0.01% 606
2024
Q1
$2.74M Sell
22,763
-471
-2% -$56.7K 0.01% 610
2023
Q4
$2.86M Sell
23,234
-40
-0.2% -$4.92K 0.01% 606
2023
Q3
$3.01M Buy
23,274
+2,049
+10% +$265K 0.01% 599
2023
Q2
$2.63M Buy
21,225
+1,807
+9% +$224K 0.01% 601
2023
Q1
$2.84M Buy
19,418
+2,033
+12% +$297K 0.01% 576
2022
Q4
$2.77M Sell
17,385
-402
-2% -$64K 0.01% 578
2022
Q3
$2.37M Sell
17,787
-3,448
-16% -$459K 0.01% 577
2022
Q2
$3.31M Buy
21,235
+116
+0.5% +$18.1K 0.02% 544
2022
Q1
$3.29M Buy
21,119
+884
+4% +$138K 0.01% 584
2021
Q4
$2.58M Buy
20,235
+2,099
+12% +$268K 0.01% 598
2021
Q3
$2.36M Buy
18,136
+783
+5% +$102K 0.01% 612
2021
Q2
$3.08M Hold
17,353
0.01% 604
2021
Q1
$2.85M Hold
17,353
0.01% 599
2020
Q4
$2.87M Sell
17,353
-4,345
-20% -$717K 0.02% 551
2020
Q3
$3.03M Hold
21,698
0.02% 505
2020
Q2
$2.38M Sell
21,698
-3,133
-13% -$343K 0.02% 526
2020
Q1
$2.48M Hold
24,831
0.02% 504
2019
Q4
$3.69M Hold
24,831
0.03% 494
2019
Q3
$3.18M Buy
+24,831
New +$3.18M 0.02% 517
2019
Q2
Sell
-22,667
Closed -$3.24M 613
2019
Q1
$3.24M Sell
22,667
-2,894
-11% -$414K 0.03% 526
2018
Q4
$3.11M Sell
25,561
-31,011
-55% -$3.77M 0.03% 519
2018
Q3
$5.49M Buy
56,572
+30,897
+120% +$3M 0.06% 323
2018
Q2
$4.42M Buy
+25,675
New +$4.42M 0.04% 416